Advertisement
Research Article| Volume 3, ISSUE 1, P47-53, March 1981

Download started.

Ok

Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women

DOI:https://doi.org/10.1016/0378-5122(81)90019-0
Oestrogens, gonadotropins and prolactin after intra-vaginal administration of oestriol in post-menopausal women
Previous ArticleMonitoring the pathophysiological correlates of postmenopausal hot flushes
Next ArticleOn the calculation of climacteric symptoms
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Serum total oestrone, 17β-oestradiol and oestriol concentrations and FSH, LH and prolactin values were measured radioimmunologically in post-menopausal women before and after intra-vaginal application of 0.5 mg oestriol. While oestrone and oestradiol were not altered, there was a 3100% increase in the mean oestriol values within 1 or 2 h; pre-treatment levels were again reached 8 h later. Both gonadotropins were moderately decreased, the serum prolactin values appeared to be slightly elevated.
      Repeated intra-vaginal application of oestriol resulted in a significant rise of the mean serum oestriol levels while the other oestrogens remained unchanged. The same was true for FSH and LH, a considerable negative feedback was therefore excluded. Again there seemed to be a slight rise of the prolactin secretion.
      It was concluded that intra-vaginal administration of oestriol is a most suitable local and systemic oestrogen replacement therapy, which is more effective than the oral regimen.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Yen S.S.C.
        • Martin P.L.
        • Burnier A.M.
        • Czekala N.M.
        • Greaney Jr., M.O.
        • Callantine M.R.
        Circulating estradiol, estrone and gonadotropin levels following the administration of orally active 17β-estradiol in postmenopausal women.
        J. Clin. Endocrinol. Metab. 1975; 40: 518-521
        • Englund D.E.
        • Johansson E.D.B.
        Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women.
        Acta Obstet. Gynecol. Scand. Suppl. 1977; 65: 27-31
        • Rauramo L.
        • Punnonen R.
        • Kaihola H.-L.
        • Grönroos M.
        Serum oestriol, oestrone and oestradiol concentrations during oral oestriol succinate treatment in ovariectomized women.
        Maturitas. 1978; 1: 71-78
        • Rauramo L.
        • Punnonen R.
        • Grönroos M.
        Serum oestrone, oestradiol and oestriol concentrations during oral oestradiol valerate and oestriol succinate therapy in ovariectomized women.
        Maturitas. 1978; 1: 79-85
        • Strecker J.R.
        • Lauritzen Ch.
        • Goessens L.
        Plasma concentrations of unconjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oophorectomy and in the menopause.
        Maturitas. 1979; 1: 183-190
        • Widholm O.
        • Vartiainen E.
        The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina.
        Ann. Chir. Gynaecol. Fenn. 1974; 63: 186-190
        • Rigg L.A.
        • Milanes B.
        • Villanueva B.
        • Yen S.S.C.
        Efficacy of intravaginal and intranasal administration of micronized estradiol-17.
        J. Clin. Endocrinol. Metab. 1977; 45: 1261-1264
        • Schiff I.
        • Tulchinsky D.
        • Ryan K.J.
        Vaginal absorption of estrone and 17β-estradiol.
        American Fertility Society. 1977; Vol. 28
        • Genazzani A.R.
        • Inaudi P.
        • La Rosa R.
        • De Leo V.
        • Ricci-Danero M.G.
        • Danero S.
        Estriol and Menopause. Clinical and endocrinological results of vaginal administration.
        in: International Symposium on the Menopause, Viareggio1980
        • Kicovic P.M.
        • Cortes-Prieto J.
        • Milojevic S.
        • Haspels A.A.
        • Aljinovic A.
        The treatment of postmenopausal vaginal atrophy with ovestin vaginal cream or suppositoria: clinical, endocrinological and safety aspects.
        in: International Symposium on the Menopause, Viareggio1980
        • Englund D.E.
        • Johansson E.D.B.
        A pharmacokinetic study on oestriol.
        in: Endometrial effect of estriol treatment in postmenopausal women. Acta Endocrinol. (Copenhagen). 1979: 109 (Suppl. 225)
        • Keller P.J.
        The effect of natural sex steroids on the excretion of follicle-stimulating and luteinizing hormones in postmenopausal women.
        Acta Endocrinol. (Copenhagen). 1970; 64: 479-488
        • Robyn C.
        • Deluoye P.
        • Van Exter C.
        • Vekemans M.
        • Caufriez A.
        • Demayer P.
        • Delogue-Desnoeck T.
        • L'Hermite M.
        Crosignani P.G. Robyn C. Prolactin and human reproduction. Academic Press, London1976: 32
        • L'Hermite M.
        • Badawi M.M.
        • Michaux-Duchene A.
        • Robyn C.
        Unaltered basal prolactin secretion during short-term oestriol treatment in post-menopausal women.
        Clin. Endocrinol. 1979; 11: 173-177
        • Lind T.
        • Cameron E.H.D.
        • Hunter W.M.
        Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.
        Br. J. Obstet. Gynaecol. 1978; 85: 138-141
        • Luisi M.
        • Franchi F.
        • Kicovic P.M.
        A group comparative study of effects of Ovestin cream versus Premarin cream in postmenopausal women with vaginal atrophy.
        in: International Symposium on the Menopause, Viareggio1980

      Article info

      Publication history

      Accepted: December 12, 1980
      Received: July 7, 1980

      Identification

      DOI: https://doi.org/10.1016/0378-5122(81)90019-0

      Copyright

      © 1981 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX